
By selecting any links below, you will be redirected to websites managed by third parties who are responsible for maintaining accurate, NCCN-approved translated and/or regionally-adapted materials at all times. Clicking any link below will take you to a website to which our Privacy Policy does not apply. Links are provided as a public service and for informational purposes only. No endorsement is made or implied.
NCCN held the 2nd Annual Middle East & North Africa NCCN Clinical Practice Guidelines in Oncology™ Congress in Abu Dhabi, April 23rd-26th.
We acknowledge and appreciate the generous institutional support received from the Abu Dhabi Health Services Company (SEHA) and industry support received from Novartis Oncology, Roche, GlaxoSmithKline, Bayer, Pfizer Inc, and Genomic Health, Inc.
NCCN extends special appreciation to our dedicated NCCN faculty, our MENA Program Director: Mohammed Jahanzeb, MD, University of Tennessee Cancer Institute, and our expert MENA Chairs: